Edmonton, AB. March 22, 2022: We’re thrilled to announce that BioAlberta has recognized Nobel Laureate and member of API Scientific Advisory Committee, Dr. Michael Houghton in the Alberta Bioindustry Hall of Fame.
The Alberta Bioindustry Hall of Fame recognizes individuals who have made extensive and tangible contributions to the Alberta life sciences community. This work can be in scientific achievement and research, industry development, public policy, education and ambassadorship. Inductees are selected by the Board of Directors based on the notable impact of an individual’s work or lifetime achievement. Recipients are known to be passionate advocates for science and technology, accomplished scientists, business leaders and mentors whose dedication left an indelible mark in the life sciences sector.
Dr. Michael Houghton was named the 2020 Nobel Prize winner in Physiology or Medicine along with Harvey J. Alter and Charles M. Rice in recognition of their discovery of the hepatitis C (HCV) virus. His research in the field of viral hepatitis has led to improved blood safety and hepatitis C treatment. The viral infection can now be cured in virtually all patients. Dr. Houghton has impacted thousands of lives with his ground-breaking discoveries. He is currently the Director of The Li Ka Shing Applied Virology Institute (LKSAVI) and is working on a vaccine for hepatitis C.
Here is a video of Dr. Houghton on the life sciences industry in Alberta.